Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.

Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.

Apomine, a novel 1,1 bisphosphonate ester, increases the rate of degradation of HMG-CoA reductase, inhibiting the mevalonate pathway and thereby blocking cholesterol biosynthesis. We have investigated whether Apomine can induce myeloma cell apoptosis in vitro and modulate myeloma disease in vivo. Ap...

Bibliografiset tiedot
Päätekijät:	Edwards, C, Mueller, G, Roelofs, A, Chantry, A, Perry, M, Russell, R, Van Camp, B, Guyon-Gellin, Y, Niesor, E, Bentzen, C, Vanderkerken, K, Croucher, P
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2007

Samankaltaisia teoksia

Apomine, an inhibitor of HMG-COA-reductase, does not act by inhibiting protein prenylation in human myeloma cells in vitro
Tekijä: Roelofs, A, et al.
Julkaistu: (2005)

APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.
Tekijä: Croucher, P, et al.
Julkaistu: (2002)

Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Tekijä: Roelofs, A, et al.
Julkaistu: (2007)

Novel insights into the anti-tumour mechanism of action of apomine and its synergistic interaction with lovastatin in myeloma cells in vitro
Tekijä: Roelofs, A, et al.
Julkaistu: (2006)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
Tekijä: Croucher, P, et al.
Julkaistu: (2003)

Myeloma cells can promote osteoclastic activity rather than osteoclast recruitment in vitro; Evidence from the 5T2MM murine model of myeloma
Tekijä: Mueller, G, et al.
Julkaistu: (2004)

5T2MM murine myeloma cells and CD138+ve human myeloma cells promote osteoclastic activity rather than osteoclast formation in vitro
Tekijä: Mueller, G, et al.
Julkaistu: (2004)

HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
Tekijä: Aronson, J, et al.
Julkaistu: (1990)

Pleiotropic effects of the HMG-CoA reductase inhibitors
Tekijä: Mihos CG, et al.
Julkaistu: (2011-04-01)

Regulation of HMG-CoA reductase activity in plants.
Tekijä: B A Stermer, et al.
Julkaistu: (1994-07-01)

Activation of HMG-CoA reductase by microsomal phosphatase
Tekijä: K R Feingold, et al.
Julkaistu: (1983-03-01)

The discovery and development of HMG-CoA reductase inhibitors.
Tekijä: A Endo
Julkaistu: (1992-11-01)

HMG-CoA reductase kinase: measurement of activity by methods that preclude interference by inhibitors of HMG-CoA reductase activity or by mevalonate kinase.
Tekijä: H J Harwood, Jr, et al.
Julkaistu: (1982-07-01)

Bisphosphonates--mechanisms of action in multiple myeloma.
Tekijä: Shipman, C, et al.
Julkaistu: (2000)

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.
Tekijä: Shipman, C, et al.
Julkaistu: (2000)

Osteoprotegerin and the development of myeloma bone disease
Tekijä: Croucher, P, et al.
Julkaistu: (2004)

HMG CoA reductase of intestinal mucosa and liver of the rat
Tekijä: S. Shefer, et al.
Julkaistu: (1972-05-01)

HMG-CoA reductase is not the site of the primary defect in phytosterolemia
Tekijä: G.M.B. Berger, et al.
Julkaistu: (1998-05-01)

Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression.
Tekijä: JJ Hwa, et al.
Julkaistu: (1992-05-01)

Bisphosphonates and in vivo models of multiple myeloma - Reply
Tekijä: Shipman, C, et al.
Julkaistu: (2001)

The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase
Tekijä: Marc M Schumacher, et al.
Julkaistu: (2015-03-01)

Stimulatory effect of dietary lipid and cholestyramine on hepatic HMG CoA reductase
Tekijä: Stanley Goldfarb, et al.
Julkaistu: (1972-11-01)

QSAR Regression Models for Predicting HMG-CoA Reductase Inhibition
Tekijä: Robert Ancuceanu, et al.
Julkaistu: (2024-10-01)

HMG-CoA Reductase Inhibitors from Monascus-Fermented Rice
Tekijä: Xuemei Li, et al.
Julkaistu: (2013-01-01)

Eupatilin Alleviates Hyperlipidemia in Mice by Inhibiting HMG-CoA Reductase
Tekijä: Kyung-Joo Kim, et al.
Julkaistu: (2023-01-01)

The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation
Tekijä: Paolo Gelosa, et al.
Julkaistu: (2007-11-01)

Induction of HMG CoA reductase by the administration of 20,25-diazacholesterol
Tekijä: R Langdon, et al.
Julkaistu: (1977-01-01)

MTD–CoMSIA modelling of HMG-CoA reductase inhibitors
Tekijä: DANIEL M. DUDA-SEIMAN, et al.
Julkaistu: (2011-01-01)

Measurement of human leukocyte microsomal HMG-CoA reductase activity.
Tekijä: H J Harwood, Jr, et al.
Julkaistu: (1984-09-01)

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
Tekijä: Jobin Jean, et al.
Julkaistu: (2004-05-01)

Diurnal variation of HMG CoA reductase activity in rat intestine
Tekijä: S. Shefer, et al.
Julkaistu: (1972-09-01)

Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy
Tekijä: Noel Lorenzo Villalba, et al.
Julkaistu: (2021-06-01)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Tekijä: Croucher, P, et al.
Julkaistu: (2001)

Mutations within the membrane domain of HMG-CoA reductase confer resistance to sterol-accelerated degradation
Tekijä: Peter C.W. Lee, et al.
Julkaistu: (2007-02-01)

Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity
Tekijä: Gene C. Ness, et al.
Julkaistu: (1998-01-01)

Rapid reverse phase-HPLC assay of HMG-CoA reductase activity
Tekijä: Matteo Mozzicafreddo, et al.
Julkaistu: (2010-08-01)

Inactivation of rat liver HMG-CoA reductase phosphatases by polycarboxylic acids.
Tekijä: F G Hegardt, et al.
Julkaistu: (1983-07-01)

Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor
Tekijä: Sucharita Bose, et al.
Julkaistu: (2023-04-01)

Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
Tekijä: Hongwen Chen, et al.
Julkaistu: (2022-07-01)

Are Point Mutations in HMG-CoA Reductases (Hmg1 and Hmg2) a Step towards Azole Resistance in <i>Aspergillus fumigatus</i>?
Tekijä: Irene Gonzalez-Jimenez, et al.
Julkaistu: (2021-10-01)